Dechra Pharmaceuticals -ADRDPHAY
13F holders, Q1 2024 (March 31)1holders
$98.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Dechra Pharmaceuticals -ADR (DPHAY) in their 13F filings. The largest holder was Rhumbline Advisers ($3K).
- Company
- Dechra Pharmaceuticals -ADR
- CUSIP
- 243435104
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | No change | 34 | $3K |
"% of holder's portfolio" is DPHAY's weight in each manager's 13F, not the share of Dechra Pharmaceuticals -ADR the manager owns.